Medical experts have said pairing the medications with a science-backed lifestyle modification program can help with long-term weight management.
“WeightWatchers’ nutrition and behavior-change program can provide the support needed to help people build livable healthy habits for the long term and manage the dietary-induced side effects often felt while taking chronic weight management medications, such as glucagon-like peptide-1s ,” Dr. Gary Foster, chief scientific officer of WeightWatchers, said.
WeightWatchers will pay $106 million to acquire Sequence. The move will give WeightWatchers a foothold into the growing prescription drug market for addressing obesity and other weight conditions. Adults with obesity are at increased risk for many other serious health conditions such as heart disease, stroke, type 2 diabetes, some cancers, and poorer mental health,
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why Weight Watchers is buying a company that prescribes popular weight-loss drugs like OzempicIt's the latest example how a new class of therapies has revolutionized the way many Americans think about weight loss. I’m diabetic, I went to the pharmacy to pick up my prescription for Ozempic, I was told there was a shortage, they didn’t know when it was coming, so while waiting my blood sugar went yo 800, & I was hospitalized for 4 days trying to get my blood sugar under control. Shame on you
Source: MarketWatch - 🏆 3. / 97 Read more »
Weight Watchers moves into obesity drugs market with purchase of telehealth companyWeight Watchers acquired a telehealth platform that provides telemedicine appointments with doctors who can prescribe popular medications like Ozempic and Wegovy. no wonder diabetic patients can't get their meds Easy to get a doctor to prescribe these meds. But much, much harder to get them. Most insurances don't over it for weight loss and it is over $1,000/month out of pocket. One big pharmaceutical monopoly
Source: ABC - 🏆 471. / 51 Read more »
WeightWatchers buys telehealth platform Sequence, facilitating access to Ozempic and WegovyThe diet company is hoping to offer members the ability to meet with clinicians who can prescribe obesity and diabetes medications. 🖤 What good is this if it’s not covered by insurance. $1600/month is out of reach for anyone who actually needs it! Move more, eat less. Now give me money for this new diet.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Obesity drugs have heft beyond Weight WatchersThe first effective obesity therapies are just starting to have effects beyond their pharma developers and patients. WW International’s purchase of a telehealth prescriber is a pivot, but one that may help its existing business. Other firms will follow.
Source: Breakingviews - 🏆 470. / 51 Read more »